Vita Life Sciences Ltd
ASX:VLS
Vita Life Sciences Ltd
Net Income (Common)
Vita Life Sciences Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita Life Sciences Ltd
ASX:VLS
|
Net Income (Common)
AU$9.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
30%
|
CAGR 10-Years
7%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Net Income (Common)
AU$117.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Net Income (Common)
AU$157.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Net Income (Common)
-AU$14.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-24%
|
|
Probiotec Ltd
ASX:PBP
|
Net Income (Common)
AU$8.7m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
21%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Net Income (Common)
-AU$24.6m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita Life Sciences Ltd's Net Income (Common)?
Net Income (Common)
9.1m
AUD
Based on the financial report for Dec 31, 2023, Vita Life Sciences Ltd's Net Income (Common) amounts to 9.1m AUD.
What is Vita Life Sciences Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%
Over the last year, the Net Income (Common) growth was 28%. The average annual Net Income (Common) growth rates for Vita Life Sciences Ltd have been 14% over the past three years , 30% over the past five years , and 7% over the past ten years .